Corrigendum to "Bleomycin induced lung fibrosis increases work of breathing in the mouse" [Pulm. Pharmacol.Therapeut. 25 (2012) 281-285]
Pulm Pharmacol Ther
.
2022 Jun:73-74:102122.
doi: 10.1016/j.pupt.2022.102122.
Epub 2022 Mar 3.
Authors
Jonathan E Phillips
1
,
Ruoqi Peng
2
,
Lisa Burns
2
,
Paul Harris
2
,
Rosario Garrido
2
,
Gaurav Tyagi
2
,
Jay S Fine
2
,
Christopher S Stevenson
2
Affiliations
1
Hoffmann-La Roche, pRED, Pharma Research & Early Development, DTA Inflammation, 340 Kingsland Street, Nutley, NJ, 07110, USA. Electronic address: Jonathan.phillips@amgen.com.
2
Hoffmann-La Roche, pRED, Pharma Research & Early Development, DTA Inflammation, 340 Kingsland Street, Nutley, NJ, 07110, USA.
PMID:
35248466
DOI:
10.1016/j.pupt.2022.102122
No abstract available
Publication types
Published Erratum